Efforts to Allow FDA Oversight of Clinical Laboratory-Developed Tests Continue in New Congress
The VALID Act has been refiled and the FDA has declared its intent to issue a proposed rule to enable it to oversee LDTs Should the federal Food and Drug Administration (FDA) have the authority to regulate laboratory-developed tests (LDT)? Advocates in favor of this outcome are working to make FDA oversight of LDTs a […]
The post <strong>Efforts to Allow FDA Oversight of Clinical Laboratory-Developed Tests Continue in New Congress</strong> appeared first on Dark Daily.
Source: Dark Daily - Category: Laboratory Medicine Authors: Jillia Schlingman Tags: Compliance, Legal, and Malpractice Laboratory Management and Operations Laboratory News Laboratory Testing Pathology and Clinical Laboratory Conferences 2023 Executive War College on Diagnostics Clinical Laboratory and Pathology Management ACL Source Type: news
More News: Conferences | Food and Drug Administration (FDA) | Laboratory Medicine | Legislation | Malpractice | Pathology | Politics